ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HER2 Antibody Drug Conjugate Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-14Q19170
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global HER2 Antibody Drug Conjugate Market Research Report 2025
BUY CHAPTERS

Global HER2 Antibody Drug Conjugate Market Research Report 2025

Code: QYRE-Auto-14Q19170
Report
March 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Daiichi Sankyo
RemeGen, Ltd.

HER2 Antibody Drug Conjugate Market Size

The global market for HER2 Antibody Drug Conjugate was valued at US$ 6231 million in the year 2024 and is projected to reach a revised size of US$ 18480 million by 2031, growing at a CAGR of 16.8% during the forecast period.

HER2 Antibody Drug Conjugate Market

HER2 Antibody Drug Conjugate Market

HER2 antibody-drug conjugate (ADC) is an innovative, targeted anticancer therapy that combines monoclonal antibodies specific to human epidermal growth factor receptor 2 (HER2) with potent cytotoxic drugs via ligons. This antibody is responsible for recognizing and binding to the surface of HER2-positive cancer cells, delivering the drug precisely to the tumor cells, and then releasing the drug inside the cancer cells to induce cell death, thus effectively inhibiting tumor growth, while reducing damage to normal cells, improving treatment effectiveness and reducing side effects. It shows a good application prospect in the treatment of HER2-positive cancers such as breast cancer and gastric cancer.
North American market for HER2 Antibody Drug Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HER2 Antibody Drug Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of HER2 Antibody Drug Conjugate include Roche, Daiichi Sankyo, RemeGen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HER2 Antibody Drug Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Antibody Drug Conjugate.
The HER2 Antibody Drug Conjugate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 Antibody Drug Conjugate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Antibody Drug Conjugate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HER2 Antibody Drug Conjugate Market Report

Report Metric Details
Report Name HER2 Antibody Drug Conjugate Market
Accounted market size in year US$ 6231 million
Forecasted market size in 2031 US$ 18480 million
CAGR 16.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 100mg/ bottle
  • 440mg/ bottle
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Daiichi Sankyo, RemeGen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HER2 Antibody Drug Conjugate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HER2 Antibody Drug Conjugate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is HER2 Antibody Drug Conjugate Market growing?

Ans: The HER2 Antibody Drug Conjugate Market witnessing a CAGR of 16.8% during the forecast period 2025-2031.

What is the HER2 Antibody Drug Conjugate Market size in 2031?

Ans: The HER2 Antibody Drug Conjugate Market size in 2031 will be US$ 18480 million.

Who are the main players in the HER2 Antibody Drug Conjugate Market report?

Ans: The main players in the HER2 Antibody Drug Conjugate Market are Roche, Daiichi Sankyo, RemeGen

What are the Application segmentation covered in the HER2 Antibody Drug Conjugate Market report?

Ans: The Applications covered in the HER2 Antibody Drug Conjugate Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the HER2 Antibody Drug Conjugate Market report?

Ans: The Types covered in the HER2 Antibody Drug Conjugate Market report are 100mg/ bottle, 440mg/ bottle

Recommended Reports

Antibody Drug Conjugates

Breast Cancer Targeted

HER2 and Trastuzumab

1 HER2 Antibody Drug Conjugate Market Overview
1.1 Product Definition
1.2 HER2 Antibody Drug Conjugate by Type
1.2.1 Global HER2 Antibody Drug Conjugate Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg/ bottle
1.2.3 440mg/ bottle
1.3 HER2 Antibody Drug Conjugate by Application
1.3.1 Global HER2 Antibody Drug Conjugate Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global HER2 Antibody Drug Conjugate Market Size Estimates and Forecasts
1.4.1 Global HER2 Antibody Drug Conjugate Revenue 2020-2031
1.4.2 Global HER2 Antibody Drug Conjugate Sales 2020-2031
1.4.3 Global HER2 Antibody Drug Conjugate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HER2 Antibody Drug Conjugate Market Competition by Manufacturers
2.1 Global HER2 Antibody Drug Conjugate Sales Market Share by Manufacturers (2020-2025)
2.2 Global HER2 Antibody Drug Conjugate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HER2 Antibody Drug Conjugate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HER2 Antibody Drug Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Product Type & Application
2.7 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Date of Enter into This Industry
2.8 Global HER2 Antibody Drug Conjugate Market Competitive Situation and Trends
2.8.1 Global HER2 Antibody Drug Conjugate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HER2 Antibody Drug Conjugate Players Market Share by Revenue
2.8.3 Global HER2 Antibody Drug Conjugate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 Antibody Drug Conjugate Market Scenario by Region
3.1 Global HER2 Antibody Drug Conjugate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HER2 Antibody Drug Conjugate Sales by Region: 2020-2031
3.2.1 Global HER2 Antibody Drug Conjugate Sales by Region: 2020-2025
3.2.2 Global HER2 Antibody Drug Conjugate Sales by Region: 2026-2031
3.3 Global HER2 Antibody Drug Conjugate Revenue by Region: 2020-2031
3.3.1 Global HER2 Antibody Drug Conjugate Revenue by Region: 2020-2025
3.3.2 Global HER2 Antibody Drug Conjugate Revenue by Region: 2026-2031
3.4 North America HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.4.1 North America HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.4.3 North America HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.5.1 Europe HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.5.3 Europe HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 Antibody Drug Conjugate Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 Antibody Drug Conjugate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HER2 Antibody Drug Conjugate Sales by Region (2020-2031)
3.6.3 Asia Pacific HER2 Antibody Drug Conjugate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.7.1 Latin America HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.7.3 Latin America HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.8.3 Middle East and Africa HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 Antibody Drug Conjugate Sales by Type (2020-2031)
4.1.1 Global HER2 Antibody Drug Conjugate Sales by Type (2020-2025)
4.1.2 Global HER2 Antibody Drug Conjugate Sales by Type (2026-2031)
4.1.3 Global HER2 Antibody Drug Conjugate Sales Market Share by Type (2020-2031)
4.2 Global HER2 Antibody Drug Conjugate Revenue by Type (2020-2031)
4.2.1 Global HER2 Antibody Drug Conjugate Revenue by Type (2020-2025)
4.2.2 Global HER2 Antibody Drug Conjugate Revenue by Type (2026-2031)
4.2.3 Global HER2 Antibody Drug Conjugate Revenue Market Share by Type (2020-2031)
4.3 Global HER2 Antibody Drug Conjugate Price by Type (2020-2031)
5 Segment by Application
5.1 Global HER2 Antibody Drug Conjugate Sales by Application (2020-2031)
5.1.1 Global HER2 Antibody Drug Conjugate Sales by Application (2020-2025)
5.1.2 Global HER2 Antibody Drug Conjugate Sales by Application (2026-2031)
5.1.3 Global HER2 Antibody Drug Conjugate Sales Market Share by Application (2020-2031)
5.2 Global HER2 Antibody Drug Conjugate Revenue by Application (2020-2031)
5.2.1 Global HER2 Antibody Drug Conjugate Revenue by Application (2020-2025)
5.2.2 Global HER2 Antibody Drug Conjugate Revenue by Application (2026-2031)
5.2.3 Global HER2 Antibody Drug Conjugate Revenue Market Share by Application (2020-2031)
5.3 Global HER2 Antibody Drug Conjugate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche HER2 Antibody Drug Conjugate Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Daiichi Sankyo
6.2.1 Daiichi Sankyo Company Information
6.2.2 Daiichi Sankyo Description and Business Overview
6.2.3 Daiichi Sankyo HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo HER2 Antibody Drug Conjugate Product Portfolio
6.2.5 Daiichi Sankyo Recent Developments/Updates
6.3 RemeGen
6.3.1 RemeGen Company Information
6.3.2 RemeGen Description and Business Overview
6.3.3 RemeGen HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RemeGen HER2 Antibody Drug Conjugate Product Portfolio
6.3.5 RemeGen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 Antibody Drug Conjugate Industry Chain Analysis
7.2 HER2 Antibody Drug Conjugate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 Antibody Drug Conjugate Production Mode & Process Analysis
7.4 HER2 Antibody Drug Conjugate Sales and Marketing
7.4.1 HER2 Antibody Drug Conjugate Sales Channels
7.4.2 HER2 Antibody Drug Conjugate Distributors
7.5 HER2 Antibody Drug Conjugate Customer Analysis
8 HER2 Antibody Drug Conjugate Market Dynamics
8.1 HER2 Antibody Drug Conjugate Industry Trends
8.2 HER2 Antibody Drug Conjugate Market Drivers
8.3 HER2 Antibody Drug Conjugate Market Challenges
8.4 HER2 Antibody Drug Conjugate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Daiichi Sankyo
RemeGen, Ltd.
List of Tables
 Table 1. Global HER2 Antibody Drug Conjugate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global HER2 Antibody Drug Conjugate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global HER2 Antibody Drug Conjugate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global HER2 Antibody Drug Conjugate Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global HER2 Antibody Drug Conjugate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global HER2 Antibody Drug Conjugate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global HER2 Antibody Drug Conjugate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market HER2 Antibody Drug Conjugate Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of HER2 Antibody Drug Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HER2 Antibody Drug Conjugate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HER2 Antibody Drug Conjugate, Product Type & Application
 Table 12. Global Key Manufacturers of HER2 Antibody Drug Conjugate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HER2 Antibody Drug Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibody Drug Conjugate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HER2 Antibody Drug Conjugate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global HER2 Antibody Drug Conjugate Sales by Region (2020-2025) & (K Units)
 Table 18. Global HER2 Antibody Drug Conjugate Sales Market Share by Region (2020-2025)
 Table 19. Global HER2 Antibody Drug Conjugate Sales by Region (2026-2031) & (K Units)
 Table 20. Global HER2 Antibody Drug Conjugate Sales Market Share by Region (2026-2031)
 Table 21. Global HER2 Antibody Drug Conjugate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global HER2 Antibody Drug Conjugate Revenue Market Share by Region (2020-2025)
 Table 23. Global HER2 Antibody Drug Conjugate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global HER2 Antibody Drug Conjugate Revenue Market Share by Region (2026-2031)
 Table 25. North America HER2 Antibody Drug Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America HER2 Antibody Drug Conjugate Sales by Country (2020-2025) & (K Units)
 Table 27. North America HER2 Antibody Drug Conjugate Sales by Country (2026-2031) & (K Units)
 Table 28. North America HER2 Antibody Drug Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America HER2 Antibody Drug Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe HER2 Antibody Drug Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe HER2 Antibody Drug Conjugate Sales by Country (2020-2025) & (K Units)
 Table 32. Europe HER2 Antibody Drug Conjugate Sales by Country (2026-2031) & (K Units)
 Table 33. Europe HER2 Antibody Drug Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe HER2 Antibody Drug Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific HER2 Antibody Drug Conjugate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific HER2 Antibody Drug Conjugate Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific HER2 Antibody Drug Conjugate Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific HER2 Antibody Drug Conjugate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific HER2 Antibody Drug Conjugate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America HER2 Antibody Drug Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America HER2 Antibody Drug Conjugate Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America HER2 Antibody Drug Conjugate Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America HER2 Antibody Drug Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America HER2 Antibody Drug Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa HER2 Antibody Drug Conjugate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa HER2 Antibody Drug Conjugate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa HER2 Antibody Drug Conjugate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global HER2 Antibody Drug Conjugate Sales (K Units) by Type (2020-2025)
 Table 51. Global HER2 Antibody Drug Conjugate Sales (K Units) by Type (2026-2031)
 Table 52. Global HER2 Antibody Drug Conjugate Sales Market Share by Type (2020-2025)
 Table 53. Global HER2 Antibody Drug Conjugate Sales Market Share by Type (2026-2031)
 Table 54. Global HER2 Antibody Drug Conjugate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global HER2 Antibody Drug Conjugate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global HER2 Antibody Drug Conjugate Revenue Market Share by Type (2020-2025)
 Table 57. Global HER2 Antibody Drug Conjugate Revenue Market Share by Type (2026-2031)
 Table 58. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Type (2020-2025)
 Table 59. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Type (2026-2031)
 Table 60. Global HER2 Antibody Drug Conjugate Sales (K Units) by Application (2020-2025)
 Table 61. Global HER2 Antibody Drug Conjugate Sales (K Units) by Application (2026-2031)
 Table 62. Global HER2 Antibody Drug Conjugate Sales Market Share by Application (2020-2025)
 Table 63. Global HER2 Antibody Drug Conjugate Sales Market Share by Application (2026-2031)
 Table 64. Global HER2 Antibody Drug Conjugate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global HER2 Antibody Drug Conjugate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global HER2 Antibody Drug Conjugate Revenue Market Share by Application (2020-2025)
 Table 67. Global HER2 Antibody Drug Conjugate Revenue Market Share by Application (2026-2031)
 Table 68. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Application (2020-2025)
 Table 69. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche HER2 Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche HER2 Antibody Drug Conjugate Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Daiichi Sankyo Company Information
 Table 76. Daiichi Sankyo Description and Business Overview
 Table 77. Daiichi Sankyo HER2 Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Daiichi Sankyo HER2 Antibody Drug Conjugate Product
 Table 79. Daiichi Sankyo Recent Developments/Updates
 Table 80. RemeGen Company Information
 Table 81. RemeGen Description and Business Overview
 Table 82. RemeGen HER2 Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. RemeGen HER2 Antibody Drug Conjugate Product
 Table 84. RemeGen Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. HER2 Antibody Drug Conjugate Distributors List
 Table 88. HER2 Antibody Drug Conjugate Customers List
 Table 89. HER2 Antibody Drug Conjugate Market Trends
 Table 90. HER2 Antibody Drug Conjugate Market Drivers
 Table 91. HER2 Antibody Drug Conjugate Market Challenges
 Table 92. HER2 Antibody Drug Conjugate Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HER2 Antibody Drug Conjugate
 Figure 2. Global HER2 Antibody Drug Conjugate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HER2 Antibody Drug Conjugate Market Share by Type: 2024 & 2031
 Figure 4. 100mg/ bottle Product Picture
 Figure 5. 440mg/ bottle Product Picture
 Figure 6. Global HER2 Antibody Drug Conjugate Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global HER2 Antibody Drug Conjugate Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Others
 Figure 11. Global HER2 Antibody Drug Conjugate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global HER2 Antibody Drug Conjugate Market Size (2020-2031) & (US$ Million)
 Figure 13. Global HER2 Antibody Drug Conjugate Sales (2020-2031) & (K Units)
 Figure 14. Global HER2 Antibody Drug Conjugate Average Price (US$/Unit) & (2020-2031)
 Figure 15. HER2 Antibody Drug Conjugate Report Years Considered
 Figure 16. HER2 Antibody Drug Conjugate Sales Share by Manufacturers in 2024
 Figure 17. Global HER2 Antibody Drug Conjugate Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest HER2 Antibody Drug Conjugate Players: Market Share by Revenue in HER2 Antibody Drug Conjugate in 2024
 Figure 19. HER2 Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global HER2 Antibody Drug Conjugate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America HER2 Antibody Drug Conjugate Sales Market Share by Country (2020-2031)
 Figure 22. North America HER2 Antibody Drug Conjugate Revenue Market Share by Country (2020-2031)
 Figure 23. United States HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe HER2 Antibody Drug Conjugate Sales Market Share by Country (2020-2031)
 Figure 26. Europe HER2 Antibody Drug Conjugate Revenue Market Share by Country (2020-2031)
 Figure 27. Germany HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific HER2 Antibody Drug Conjugate Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific HER2 Antibody Drug Conjugate Revenue Market Share by Region (2020-2031)
 Figure 34. China HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America HER2 Antibody Drug Conjugate Sales Market Share by Country (2020-2031)
 Figure 42. Latin America HER2 Antibody Drug Conjugate Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa HER2 Antibody Drug Conjugate Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa HER2 Antibody Drug Conjugate Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE HER2 Antibody Drug Conjugate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of HER2 Antibody Drug Conjugate by Type (2020-2031)
 Figure 53. Global Revenue Market Share of HER2 Antibody Drug Conjugate by Type (2020-2031)
 Figure 54. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of HER2 Antibody Drug Conjugate by Application (2020-2031)
 Figure 56. Global Revenue Market Share of HER2 Antibody Drug Conjugate by Application (2020-2031)
 Figure 57. Global HER2 Antibody Drug Conjugate Price (US$/Unit) by Application (2020-2031)
 Figure 58. HER2 Antibody Drug Conjugate Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HER2 ADC Drugs Market Research Report 2024
Global Antibody drug Conjugates for Tumors Market Research Report 2024
Global Antibody drug Conjugates Market Insights Forecast to 2030
Global Antibody Drug Conjugate CDMO Market Research Report 2024
Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025
Global Antibody drug Conjugate ADC Payload Market Research Report 2025
Global Monoclonal Antibody ADC Drugs Market Research Report 2025
Global ADC Linkers Market Research Report 2024
Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2025
Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Highly Potent API HPAPI For Antibody drug Conjugate ADC Market Research Report 2025
Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024
Global HER2 Antibody Market Research Report 2025
Global Anti HER2 Therapy Market Research Report 2025
Global Herceptin Trastuzumab Market Research Report 2024
Global ADC Manufacturing Service Market Research Report 2025
Global Antibody radionuclide Conjugates Market Research Report 2024
Global Cancer Antibody Drug Conjugates Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions